Biotech firm Windtree Therapeutics plans to purchase up to $700 million worth of BNB, the fifth-largest cryptocurrency by market cap, marking a significant move in the evolving landscape of corporate crypto investment. Following a recent all-time high for BNB, Windtree announced it would raise $520 million to facilitate its purchasing strategy, partnering with Kraken for custody and trading services. This initiative follows the model established by companies like Strategy, which have begun investing in various digital assets beyond Bitcoin. The company's decision comes at a time when several publicly traded firms are bolstering their stock prices through strategic crypto holdings. Windtree, which trades on the Nasdaq under the ticker WINT, expects that gaining additional funds will support its BNB acquisition plans, contributing to an overall stock increase of 162% over the past month despite a recent dip. As corporate interest in cryptocurrency gains momentum, Windtree’s actions illustrate a growing acceptance and strategy around digital assets in the traditional market, diverging from Bitcoin to embrace other cryptocurrencies like BNB.

Source 🔗